<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v23i6.2833</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-3660</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Синдром CHARGE глазами детского  эндокринолога: клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>CHARGE Syndrome from Pediatric Endocrinologist Perspective:  Clinical Case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6472-7442</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кокорева</surname><given-names>К. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kokoreva</surname><given-names>Kristina D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кокорева Кристина Дмитриевна - кандидат медицинских наук, детский эндокринолог консультативно-диагностического центра; ассистент кафедры детской эндокринологии и диетологии </p><p>117292, Москва, ул. Дмитрия Ульянова, д. 11</p><p> тел.: +7 (915) 477-67-55</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">kristinadk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6470-6318</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волеводз</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Volevodz</surname><given-names>Natalia N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ эндокринологии» Минздрава России; ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre;  Moscow Regional Research and Clinical Institute n.a. M.F. Vladimirsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>05</day><month>01</month><year>2025</year></pub-date><volume>23</volume><issue>6</issue><fpage>509</fpage><lpage>515</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кокорева К.Д., Волеводз Н.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Кокорева К.Д., Волеводз Н.Н.</copyright-holder><copyright-holder xml:lang="en">Kokoreva K.D., Volevodz N.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/3660">https://vsp.spr-journal.ru/jour/article/view/3660</self-uri><abstract><p>Обоснование. Синдром CHARGE — заболевание с аутосомно-доминантным типом наследования и популяционной частотой 1 случай на 8500–15000 новорожденных. Причина заболевания — изменение нуклеотидной последовательности гена СHD7. «Большими» критериями синдрома являются колобома глаз, атрезия или стеноз хоан, дефекты средней линии (расщелина губы и/или неба) и врожденные пороки наружного, среднего и внутреннего уха. Синдром CHARGE характеризуется выраженным клиническим полиморфизмом, что усложняет диагностику заболевания. Описание клинического случая. Мальчик, возраст 5 лет, направлен к эндокринологу по поводу одностороннего крипторхизма с рождения. При осмотре обнаружены асимметрия лица, нарушение строения ушных раковин, гипоплазированная мошонка и отсутствие одного яичка в мошонке. Также отмечены колобома сетчатки с двусторонней туго ухостью, оперированная расщелина губы и неба, трудности с кормлением, жеванием и глотанием, задержка умственного развития и паралич лицевого нерва. Клинически диагностирован синдром CHARGE, впоследствии подтвержденный молекулярно-генетическим исследованием: выявлена ранее описанная патогенная гетерозиготная нуклеотидная замена chr8:60838202C&gt;T (HG38) в экзоне 19 гена СHD7. Заключение. Проявления синдрома CHARGE разнятся от пациента к пациенту, в связи с чем необходимо молекулярно-генетическое подтверждение диагноза. Пациенты с синдромом CHARGE требуют наблюдения междисциплинарной команды, а к эндокринологу обычно обращаются с жалобами на задержку роста, задержку полового развития, крипторхизм и гипоплазированные наружные половые органы. В допубертатном возрасте заподозрить гипогонадотропный гипогонадизм у мальчика с синдромом CHARGE возможно на основании сочетания одно- или двустороннего крипторхизма, гипоплазированных наружных половых органов и низкой концентрации ингибина B.</p></abstract><trans-abstract xml:lang="en"><p>Background. CHARGE syndrome is an autosomal dominant disease with population frequency of 1 case per 8500–15,000 newborns. The cause of this disease is nucleotide changes in the CHD7 gene. The “major” criteria for the syndrome are eye coloboma, choanal atresia or stenosis, midline defects (cleft lip and/or palate), and congenital malformations of outer, middle, and inner ear. CHARGE syndrome is characterized by significant clinical polymorphism complicating its diagnosis. Clinical case description. The boy, 5 years old, has been referred to endocrinologist due to unilateral cryptorchidism since birth. We have revealed face asymmetry, auricles abnormalities, hypoplastic scrotum and absence of one testicle in the scrotum during examination. Retinal coloboma, bilateral hearing loss, operated cleft lip and palate, difficulties with feeding, chewing, and swallowing, mental retardation and facial paralysis were also noted. CHARGE syndrome was clinically diagnosed, and later it was confirmed by molecular genetic testing: previously described pathogenic heterozygous nucleotide variant chr8:60838202C&gt;T (HG38) in exon 19 of the CHD7 gene was revealed. Conclusion.  Manifestations of CHARGE syndrome vary from patient to patient, thus, molecular genetic confirmation of the diagnosis is crucial. Patients with CHARGE syndrome require follow-up by multi-disciplinary team, and the endocrinologist is usually admitted with complaints on growth retardation, delayed puberty, cryptorchidism and hypoplastic external genitalia. It is possible to suspect hypogonadotropic hypogonadism in a boy with CHARGE syndrome at pre-pubertal age in case of its combination with one- or bilateral cryptorchidism, hypoplastic external genitalia and low inhibin B level.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром CHARGE</kwd><kwd>ген CHD7</kwd><kwd>атрезия хоан</kwd><kwd>колобома</kwd><kwd>аплазия полукружных каналов</kwd><kwd>гипогонадотропный гипогонадизм</kwd><kwd>аносмия</kwd><kwd>ингибин B</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>CHARGE syndrome</kwd><kwd>CHD7 gene</kwd><kwd>choanal atresia</kwd><kwd>coloboma</kwd><kwd>semicircular canals aplasia</kwd><kwd>hypogonadotropic hypogonadism</kwd><kwd>anosmia</kwd><kwd>inhibin B</kwd><kwd>clinical case</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Молекулярно-генетическое исследование проведено с использованием денежных средств, предоставленных благотворительным фондом поддержки и развития  филантропии «КАФ»</funding-statement><funding-statement xml:lang="en">Molecular genetic testing was performed by means  provided by the charitable foundation for philanthropy  development “CAF”.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Xu C, Cassatella D, van der Sloot AM, et al. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants. Genet Med. 2018;20(8):872–881. doi: https://doi.org/10.1038/gim.2017.197</mixed-citation><mixed-citation xml:lang="en">Xu C, Cassatella D, van der Sloot AM, et al. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants. Genet Med. 2018;20(8):872–881. doi: https://doi.org/10.1038/gim.2017.197</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Qin Z, Su J, Li M, et al. Clinical and Genetic Analysis of CHD7 Expands the Genotype and Phenotype of CHARGE Syndrome. Front Genet. 2020;11:592. doi: https://doi.org/10.3389/FGENE.2020.00592/BIBTEX</mixed-citation><mixed-citation xml:lang="en">Qin Z, Su J, Li M, et al. Clinical and Genetic Analysis of CHD7 Expands the Genotype and Phenotype of CHARGE Syndrome. Front Genet. 2020;11:592. doi: https://doi.org/10.3389/FGENE.2020.00592/BIBTEX</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Usman N, Sur M. CHARGE Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK559199. Accessed on November 27, 2024.</mixed-citation><mixed-citation xml:lang="en">Usman N, Sur M. CHARGE Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK559199. Accessed on November 27, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Delahaye A, Sznajer Y, Lyonnet S, et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet. 2027;72(2):112–121. doi: https://doi.org/10.1111/J.1399-0004.2007.00821.X</mixed-citation><mixed-citation xml:lang="en">Delahaye A, Sznajer Y, Lyonnet S, et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet. 2027;72(2):112–121. doi: https://doi.org/10.1111/J.1399-0004.2007.00821.X</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Хабибуллина Д.А., Калинченко Н.Ю., Егорова С.В. и др. Семейный случай гипогонадотропного гипогонадизма как проявление синдрома CHARGE // Проблемы эндокринологии. — 2021. — Т. 67. — № 3. — С. 68–72. — doi: https://doi.org/10.14341/PROBL12748</mixed-citation><mixed-citation xml:lang="en">Khabibullina DA, Kalinchenko NYu, Egorova SV, et al. Familial case of hypogonadotropic hypogonadism as the CHARGE syndrome manifestation. Problems of Endocrinology. 2021;67(3): 68–72. (In Russ). doi: https://doi.org/10.14341/PROBL12748</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation. A syndrome. J Pediatr Ophthalmol Strabismus. 1979;16(2):122–128. doi: https://doi.org/10.3928/0191-3913-19790301-10</mixed-citation><mixed-citation xml:lang="en">Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation. A syndrome. J Pediatr Ophthalmol Strabismus. 1979;16(2):122–128. doi: https://doi.org/10.3928/0191-3913-19790301-10</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hall BD. Choanal atresia and associated multiple anomalies. J Pediatr. 1979;95(3):395–398. doi: https://doi.org/10.1016/S0022-3476(79)80513-2</mixed-citation><mixed-citation xml:lang="en">Hall BD. Choanal atresia and associated multiple anomalies. J Pediatr. 1979;95(3):395–398. doi: https://doi.org/10.1016/ S0022-3476(79)80513-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Blake K, Davenport S, Hall B, et al. Charge association: An update and review for the primary pediatrician. Clin Pediatr (Phila). 1998;37(3):159–174. doi: https://doi.org/10.1177/000992289803700302</mixed-citation><mixed-citation xml:lang="en">Blake K, Davenport S, Hall B, et al. Charge association: An update and review for the primary pediatrician. Clin Pediatr (Phila). 1998;37(3):159–174. doi: https://doi.org/10.1177/000992289803700302</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Verloes A. Updated diagnostic criteria for CHARGE syndrome: A proposal. Am J Med Genet. 2005;133(3):306–308. doi: https://doi.org/10.1002/ajmg.a.30559</mixed-citation><mixed-citation xml:lang="en">Verloes A. Updated diagnostic criteria for CHARGE syndrome: A proposal. Am J Med Genet. 2005;133(3):306–308. doi: https:// doi.org/10.1002/ajmg.a.30559</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hale CL, Niederriter AN, Green GE, et al. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria HHS Public Access. Am J Med Genet A. 2076;170(2):344–354. doi: https://doi.org/10.1002/ajmg.a.37435</mixed-citation><mixed-citation xml:lang="en">Hale CL, Niederriter AN, Green GE, et al. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria HHS Public Access. Am J Med Genet A. 2076;170(2):344–354. doi: https://doi.org/10.1002/ajmg.a.37435</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Aramaki M, Udaka T, Kosaki R, et al. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr. 2006;148(3):410–414. doi: https://doi.org/10.1016/j.jpeds.2005.10.044</mixed-citation><mixed-citation xml:lang="en">Aramaki M, Udaka T, Kosaki R, et al. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr. 2006;148(3):410–414. doi: https://doi.org/10.1016/j.jpeds.2005.10.044</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet. 2007;15(4):389–399. doi: https://doi.org/10.1038/sj.ejhg.5201778</mixed-citation><mixed-citation xml:lang="en">Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet. 2007;15(4):389–399. doi: https://doi.org/10.1038/ sj.ejhg.5201778</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jongmans MCJ, Admiraal RJ, Van Der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306–314. doi: https://doi.org/10.1136/JMG.2005.036061</mixed-citation><mixed-citation xml:lang="en">Jongmans MCJ, Admiraal RJ, Van Der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306–314. doi: https://doi.org/10.1136/JMG.2005.036061</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kirk J. CHARGE syndrome: major and minor medical diagnostic criteria plus later onset features. In: The CHARGE Information Pack for Practitioners. 2013. 3 p. Available online: https://www.chargesyndrome.org/wp-content/uploads/2016/03/CHARGEFactsheet-3-Clinical-Diagnosis-and-features.pdf. Accessed on November 27, 2024.</mixed-citation><mixed-citation xml:lang="en">Kirk J. CHARGE syndrome: major and minor medical diagnostic criteria plus later onset features. In: The CHARGE Information Pack for Practitioners. 2013. 3 p. Available online: https://www. chargesyndrome.org/wp-content/uploads/2016/03/CHARGEFactsheet-3-Clinical-Diagnosis-and-features.pdf. Accessed on November 27, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Song X. Identification of a novel heterozygous missense mutation of SEMA3E (c.1327G&gt;A; p. Ala443Thr) in a labor induced fetus with CHARGE syndrome. Mol Genet Genomic Med. 2020;8(1):2020. doi: https://doi.org/10.1002/MGG3.1034</mixed-citation><mixed-citation xml:lang="en">Song X. Identification of a novel heterozygous missense mutation of SEMA3E (c.1327G&gt;A; p. Ala443Thr) in a labor induced fetus with CHARGE syndrome. Mol Genet Genomic Med. 2020;8(1):2020. doi: https://doi.org/10.1002/MGG3.1034</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152(3):674–686. doi: https://doi.org/10.1002/ajmg.a.33323</mixed-citation><mixed-citation xml:lang="en">Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152(3):674–686. doi: https://doi.org/10.1002/ajmg.a.33323</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hartshorne TS, Hefner MA, Blake KD. CHARGE-syndrome. 2nd edn. Plural Publishing, Inc.; 2021.</mixed-citation><mixed-citation xml:lang="en">Hartshorne TS, Hefner MA, Blake KD. CHARGE-syndrome. 2nd edn. Plural Publishing, Inc.; 2021.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Okuno H, Mihara FR, Ohta S, et al. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations. Elife. 2017;6:e21114. doi: https://doi.org/10.7554/eLife.21114.001</mixed-citation><mixed-citation xml:lang="en">Okuno H, Mihara FR, Ohta S, et al. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations. Elife. 2017;6:e21114. doi: https://doi.org/10.7554/eLife.21114.001</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Boehm U. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadismpathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547–564. doi: https://doi.org/10.1038/nrendo.2015.112</mixed-citation><mixed-citation xml:lang="en">Boehm U. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadismpathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547–564. doi: https://doi.org/10.1038/nrendo.2015.112</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Grinspon RP. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab. 2012; 25(1-2):3–11. doi: https://doi.org/10.1515/JPEM-2011-0453/MACHINEREADABLECITATION/RIS</mixed-citation><mixed-citation xml:lang="en">Grinspon RP. Sertoli cell markers in the diagnosis of paediatric male hypogonadism. J Pediatr Endocrinol Metab. 2012; 25(1-2):3–11. doi: https://doi.org/10.1515/JPEM-2011-0453/MACHINEREADABLECITATION/RIS</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dijk DR, Bocca G, van Ravenswaaij-Arts CM. Growth in CHARGE syndrome: Optimizing care with a multidisciplinary approach. J Multidiscip Healthc. 2019;12:607–620. doi: https://doi.org/10.2147/JMDH.S175713</mixed-citation><mixed-citation xml:lang="en">Dijk DR, Bocca G, van Ravenswaaij-Arts CM. Growth in CHARGE syndrome: Optimizing care with a multidisciplinary approach. J Multidiscip Healthc. 2019;12:607–620. doi: https://doi.org/10.2147/JMDH.S175713</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Дайхес Н.А., Зеликович Е.И., Балакина А.В. и др. Особенности диагностики и ведения ребенка с СHARGE-синдромом // Российская оториноларингология. — 2022. — Т. 21. — № 3. — С. 112–121. — doi: https://doi.org/10.18692/1810-4800-2022-3-112-121</mixed-citation><mixed-citation xml:lang="en">Daikhes NA, Zelikovich EI, Balakina AV, et al. Peculiarities of diagnostics and management of a child with CHARGE syndrome. Rossiiskaya otorinolaringologiya. 2022;21(3):112–121. (In Russ). doi: https://doi.org/10.18692/1810-4800-2022-3-112-121</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Бражко Ю.А., Кураева Т.Л., Емельянов А.О. и др. CHARGE синдром у ребенка с сахарным диабетом. Взаимное влияние // Достижения науки в практику детского эндокринолога: онлайн-конференция с международным участием по орфанным и детским эндокринным заболеваниям, 4–5 декабря 2021 г. Постерная сессия. https://www.endocrincentr.ru/sites/default/files/all/EVENTS2021/conference_04-12/01.pdf.</mixed-citation><mixed-citation xml:lang="en">Brazhko YuA, Kuraeva TL, Emel’yanov AO, et al. CHARGE sindrom u rebenka s sakharnym diabetom. Vzaimnoe vliyanie. Dostizheniya nauki v praktiku detskogo endokrinologa: Online Conference with International Participation on Orphan and Pediatric Endocrine Diseases, December 4–5, 2021. Poster Session. (In Russ).] Доступно по: https://www.endocrincentr.ru/sites/default/files/all/EVENTS2021/conference_04-12/01.pdf. Ссылка активна на 27 ноября 2024.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Левиашвили Ж.Г., Савенкова Н.Д., Горкина О.К. и др. CHARGE-синдром // Российский вестник перинатологии и педиатрии. — 2020. — Т. 65. — № 1. — С. 116–121. — doi: https://doi.org/10.21508/1027-4065-2020-65-1-116-121.</mixed-citation><mixed-citation xml:lang="en">Leviashvili JG, Savenkova ND, Gorkina OK, et al. CHARGE syndrome. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2020;65:(1):116–121. (In Russ). doi: https://doi.org/10.21508/1027-4065-2020-65-1-116-121</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Бурякова С.И., Пуйда С.А. Пренатальная диагностика CHARGEсиндрома // Пренатальная диагностика. — 2021. — Т. 20. — № 4. — С. 321–327. — doi: https://doi.org/10.21516/2413-1458-2021-20-4-321-327</mixed-citation><mixed-citation xml:lang="en">Buryakova SI, Puyda SA. Prenatal diagnosis of CHARGE syndrome. Prenatal Diagnosis. 2021;20(4):321–327. (In Russ). doi: https://doi.org/10.21516/2413-1458-2021-20-4-321-327</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Vissers LELM, Admiraal R, Hurst JA, De Vries BBA. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2024;36(9):955–957. doi: https://doi.org/10.1038/NG1407</mixed-citation><mixed-citation xml:lang="en">Vissers LELM, Admiraal R, Hurst JA, De Vries BBA. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2024;36(9):955–957. doi: https://doi.org/10.1038/NG1407</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Кокорева К.Д. Врожденный изолированный гипогонадотропный гипогонадизм: клинический полиморфизм и молекулярно-генетическая гетерогенность: дис. … канд. мед. наук. — М.; 2023. — 126 с.</mixed-citation><mixed-citation xml:lang="en">Kokoreva KD. Vrozhdennyi izolirovannyi gipogonadotropnyi gipogonadizm: klinicheskii polimorfizm i molekulyarno-geneticheskaya geterogennost’. [abstract of dissertation]. Moscow; 2023. 126 p. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Marcos S, Sarfati J, Leroy C, et al. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. J Clin Endocrinol Metab. 2014;99(10):E2138–E2143. doi: https://doi.org/10.1210/jc.2014-2110</mixed-citation><mixed-citation xml:lang="en">Marcos S, Sarfati J, Leroy C, et al. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. J Clin Endocrinol Metab. 2014;99(10):E2138–E2143. doi: https://doi.org/10.1210/jc.2014-2110</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Känsäkoski J, Fagerholm R, Laitinen EM, et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res. 2014;75(5): 641–644. doi: https://doi.org/10.1038/pr.2014.23</mixed-citation><mixed-citation xml:lang="en">Känsäkoski J, Fagerholm R, Laitinen EM, et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res. 2014;75(5): 641–644. doi: https://doi.org/10.1038/pr.2014.23</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE Syndrome and Chromosome 22q11.2 Deletion Syndrome: A Comparison of Immunologic and Non-Immunologic Phenotypic Features. Pediatrics. 2009;123(5):e871. doi: https://doi.org/10.1542/PEDS.2008-3400</mixed-citation><mixed-citation xml:lang="en">Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE Syndrome and Chromosome 22q11.2 Deletion Syndrome: A Comparison of Immunologic and Non-Immunologic Phenotypic Features. Pediatrics. 2009;123(5):e871. doi: https://doi.org/10.1542/PEDS.2008-3400</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sánchez N, Hernández M, Cruz JP, Mellado C. Phenotypic spectrum of neonatal charge syndrome. Rev Chil Pediatr. 2019; 90(5):533–538. doi: https://doi.org/10.32641/rchped.v90i5.1080</mixed-citation><mixed-citation xml:lang="en">Sánchez N, Hernández M, Cruz JP, Mellado C. Phenotypic spectrum of neonatal charge syndrome. Rev Chil Pediatr. 2019; 90(5):533–538. doi: https://doi.org/10.32641/rchped.v90i5.1080</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Papaioannou VE. The T-box gene family: emerging roles in development, stem cells and cancer. Development. 2014;141(20):3819–3833. doi: https://doi.org/10.1242/DEV.104471</mixed-citation><mixed-citation xml:lang="en">Papaioannou VE. The T-box gene family: emerging roles in development, stem cells and cancer. Development. 2014;141(20):3819–3833. doi: https://doi.org/10.1242/DEV.104471</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Петруничев А.Ю., Барсуков А.Ф., Воронов В.А. Семейный случай синдрома Франческетти (OMIM 154500) с тяжелым поражением среднего уха // Российская оториноларингология. — 2019. — Т. 18. — № 100. — С. 96–101. — doi: https://doi.org/10.18692/1810-4800-2019-3-96-101</mixed-citation><mixed-citation xml:lang="en">Petrunichev AYu, Barsukov AF, Voronov VA. A family case of Franceschetti syndrome (OMIM 154500) with severe lesions of the middle ear. Rossiiskaya otorinolaringologiya. 2019;18(3):96–101. (In Russ). doi: https://doi.org/10.18692/1810-4800-2019-3-96-101</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Beaumont CA, Dunaway DJ, Padwa BL, et al. Extracraniofacial anomalies in Treacher Collins syndrome: A multicentre study of 248 patients. Int J Oral Maxillofac Surg. 2021;50(11):1471–1476. doi: https://doi.org/10.1016/J.IJOM.2021.03.001</mixed-citation><mixed-citation xml:lang="en">Beaumont CA, Dunaway DJ, Padwa BL, et al. Extracraniofacial anomalies in Treacher Collins syndrome: A multicentre study of 248 patients. Int J Oral Maxillofac Surg. 2021;50(11):1471–1476. doi: https://doi.org/10.1016/J.IJOM.2021.03.001</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Бенина А.Р., Меликян М.А. Врожденный гиперинсулинизм в составе синдрома Кабуки // Проблемы Эндокринологии. — 2022. — Т. 68. — № 5. — С. 91–96. — doi: https://doi.org/10.14341/PROBL13145-10339</mixed-citation><mixed-citation xml:lang="en">Benina AR, Melikyan MA. Congenital hyperinsulinism as a part of Kabuki syndrome. Problems of Endocrinology. 2022;68(5):91–96. (In Russ). doi: https://doi.org/10.14341/probl13145</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Кондратенко И.В., Суспицын Е.Н., Вахлярская С.С. и др. Синдром Кабуки // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. — 2017. — Т. 16. — № 4. — С. 75–83. — doi: https://doi.org/10.24287/1726-1708-2017-16-4-75-83</mixed-citation><mixed-citation xml:lang="en">Kondratenko IV, Suspitsin EN, Vakhlyarskaya SS, et al. Kabuki syndrome. Pediatric Hematology/Oncology and Immunopathology. 2017;16(4):75–83. (In Russ). doi: https://doi.org/10.24287/1726-1708-2017-16-4-75-83</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Di Candia F, Fontana P, Paglia P, et al. Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature. Eur J Pediatr. 2022;181(1):171–187. doi: https://doi.org/10.1007/s00431-021-04108-w/Published</mixed-citation><mixed-citation xml:lang="en">Di Candia F, Fontana P, Paglia P, et al. Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature. Eur J Pediatr. 2022;181(1):171–187. doi: https://doi.org/10.1007/s00431-021-04108-w/Published</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
